Loading
Total declarations
Companies
▲ Purchases (40 ops.)
▼ Sales (34 ops.)
Latest filing published 05 Apr 2010 for ULURU Inc., €7,244.
Insider track record
Disclosed buys
40
Disclosed sells
34
Signal history
No signal scores available.
Closed purchases
Market purchases
40
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
OSS Capital Management: trading record in brief
This profile gathers the share dealings of OSS Capital Management across 4 companies, led by Noven Pharmaceuticals Inc, Boulder Brands, Inc. and ULURU Inc. We count 75 filings; the first trade dates from 2 April 2007 and the latest from 1 April 2010.
The open-market side counts 40 purchases for €30.0M alongside 34 sales for €10.8M. Netting one side against the other leaves €19.2M of net buying. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 1 share grant. 2010 to date brings no purchases and 4 sales.
The median purchase comes to €394k.
Most recently, on 5 April 2010, the filings show an open-market sale worth €7,244 in ULURU Inc. The most recent open-market purchase was published on 31 March 2008, 6,780 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to OSS Capital Management
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations75 total
57,550 shares@ US$0.17Common Stock, $.001 Par ValueSEC:0000902664-10-002381:0
3,400,000 shares@ US$0.16Common Stock, $.001 Par ValueSEC:0000902664-10-002381:1
137,723 shares@ US$0.17Common Stock, $.001 Par ValueSEC:0000902664-10-002371:0
30,620 shares@ US$0.17Common Stock, $.001 Par ValueSEC:0000902664-10-002371:1
11,324 shares@ US$9.00Common Stock ($.0001 par value)SEC:0000902664-09-001108:0
232,000 shares@ US$9.02Common Stock ($.0001 par value)SEC:0000902664-09-001099:0
1,100 shares@ US$9.34Common Stock ($.0001 par value)SEC:0000902664-09-001099:1
529 shares@ US$9.65Common Stock ($.0001 par value)SEC:0000902664-09-001083:0
7,000 shares@ US$9.65Common Stock ($.0001 par value)SEC:0000902664-09-001048:0
5,398 shares@ US$9.65Common Stock ($.0001 par value)SEC:0000902664-09-001048:1
17,000 shares@ US$9.68Common Stock ($.0001 par value)SEC:0000902664-09-001041:0
10,000 shares@ US$9.65Common Stock ($.0001 par value)SEC:0000902664-09-001041:1
14,140 shares@ US$10.01Common Stock ($.0001 par value)SEC:0000902664-09-000924:0
21,561 shares@ US$9.91Common Stock ($.0001 par value)SEC:0000902664-09-000924:1
25,000 shares@ US$10.10Common Stock ($.0001 par value)SEC:0000902664-09-000284:0
25,000 shares@ US$9.98Common Stock ($.0001 par value)SEC:0000902664-09-000284:1
50,000 shares@ US$10.32Common Stock ($.0001 par value)SEC:0000902664-09-000233:0
50,000 shares@ US$10.55Common Stock ($.0001 par value)SEC:0000902664-09-000233:1
100,000 shares@ US$11.00Common Stock ($.0001 par value)SEC:0000902664-09-000134:0
7,989 shares@ US$11.00Common Stock ($.0001 par value)SEC:0000902664-09-000050:0
50,000 shares@ US$11.16Common Stock ($.0001 par value)SEC:0000902664-09-000039:0
29,039 shares@ US$11.09Common Stock ($.0001 par value)SEC:0000902664-09-000039:1
66,290 shares@ US$11.01Common Stock ($.0001 par value)SEC:0000902664-09-000023:0
50,000 shares@ US$11.05Common Stock ($.0001 par value)SEC:0000902664-09-000023:1
74,409 shares@ US$11.00Common Stock ($.0001 par value)SEC:0000902664-09-000011:0
25 of 75 declarations
